June 12, 2026
Pfizer Inches Up on Heavy Volume: Worth a Look at 9.2x Earnings?
Pfizer rose 2.23% on above-average volume Friday. With a forward P/E of 9.2 and a deep pipeline, the question is whether the Street has been too harsh.